- Home
- POLE vs BLDE Comparison
POLE vs BLDE Comparison
Compare POLE & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLE
- BLDE
- Stock Information
- Founded
- POLE 2024
- BLDE 2014
- Country
- POLE United States
- BLDE United States
- Employees
- POLE N/A
- BLDE N/A
- Industry
- POLE
- BLDE Aerospace
- Sector
- POLE
- BLDE Consumer Discretionary
- Exchange
- POLE NYSE
- BLDE Nasdaq
- Market Cap
- POLE 296.0M
- BLDE 272.5M
- IPO Year
- POLE 2024
- BLDE N/A
- Fundamental
- Price
- POLE $10.11
- BLDE $3.14
- Analyst Decision
- POLE
- BLDE Strong Buy
- Analyst Count
- POLE 0
- BLDE 2
- Target Price
- POLE N/A
- BLDE $6.25
- AVG Volume (30 Days)
- POLE 3.7K
- BLDE 714.7K
- Earning Date
- POLE 01-01-0001
- BLDE 03-13-2025
- Dividend Yield
- POLE N/A
- BLDE N/A
- EPS Growth
- POLE N/A
- BLDE N/A
- EPS
- POLE N/A
- BLDE N/A
- Revenue
- POLE N/A
- BLDE $248,693,000.00
- Revenue This Year
- POLE N/A
- BLDE $5.29
- Revenue Next Year
- POLE N/A
- BLDE $8.99
- P/E Ratio
- POLE N/A
- BLDE N/A
- Revenue Growth
- POLE N/A
- BLDE 10.44
- 52 Week Low
- POLE $9.94
- BLDE $2.45
- 52 Week High
- POLE $11.16
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- POLE N/A
- BLDE 42.26
- Support Level
- POLE N/A
- BLDE $2.81
- Resistance Level
- POLE N/A
- BLDE $3.77
- Average True Range (ATR)
- POLE 0.00
- BLDE 0.23
- MACD
- POLE 0.00
- BLDE -0.01
- Stochastic Oscillator
- POLE 0.00
- BLDE 34.38
About POLE ANDRETTI ACQUISITION CORP. II
Andretti Acquisition Corp II is a blank check company.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.